Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Apr 28, 2005; 11(16): 2402-2407
Published online Apr 28, 2005. doi: 10.3748/wjg.v11.i16.2402
Published online Apr 28, 2005. doi: 10.3748/wjg.v11.i16.2402
C3-MODE | Pathological diagnosis | |||
HCC | Metastatic tumor | Hemangioma | Lipid degeneration | |
HCC | 27 | 0 | 1 | 0 |
Metastatic tumor | 0 | 5 | 0 | 0 |
Hemangioma | 0 | 1 | 9 | 3 |
Pathological diagnosis | Sensitivity | Specificity | Accuracy | |||
Malignant | Benign | |||||
C3-MODE | Malignant | 32 | 1 | 97.0% | 92.3% | 95.7% |
Benign | 1 | 12 | ||||
CT | Malignant | 32 | 2 | 94.1% | 91.7% | 93.5% |
Benign | 1 | 11 | ||||
Total | 33 | 13 |
- Citation: Luo BM, Wen YL, Yang HY, Zhi H, Ou B, Ma JH, Pan JS, Dai XN. Differentiation between malignant and benign nodules in the liver: Use of contrast C3-MODE technology. World J Gastroenterol 2005; 11(16): 2402-2407
- URL: https://www.wjgnet.com/1007-9327/full/v11/i16/2402.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i16.2402